Emerging Trends and Innovations for the Glaucoma Surgery Devices Market | projected to reach USD 5.63 Billion by 2032

According to a research report “Glaucoma Surgery Devices Market," by Surgery Type (MIGS, Laser Surgery, Traditional Glaucoma Surgery, Others), Product (Laser Systems, Diamond Knives, Glaucoma Drainage Device, Probes, Others), Treatment (Open-Angle glaucoma, Closed-Angle Glaucoma, Others), End User (Hospitals, Private Ophthalmic Clinics and ASCs, Others) & Region - Global Forecast To 2032.

Glaucoma Surgery Devices Market was valued USD 1.23 Billion in 2023 and projected to reach USD 5.63 Billion by 2032, growing at a CAGR of 19.1% during the forecast period of 2024-2032.

Download Sample Pages - https://www.marketdigits.com/request/sample/1025

Browse in-depth TOC on Glaucoma Surgery Devices Market

• 324 - Tables
• 56 - Figures
• 370 - Pages

Market Overview: According to the World Health Organization (WHO), Global Glaucoma prevalence stands at about 6.9 million people. The increase in visual impairment also presents significant social and economic challenges. Eye disorders, including cataracts and glaucoma, affect people in China, India, and sub-Saharan Africa. Others are affected by diseases such as trachoma, glaucoma, onchocerciasis, and other common illnesses in young individuals. VISION 2020: Right to Sight-INDIA, established in 2004, is a partnership between the WHO, the International Agency for the Prevention of Blindness (IAPB), and the Indian government. Over the last few years, the options for surgical devices have more than doubled, and we expect this rapid expansion to continue over the next five years with a lot of new devices in development. Recently, there has been a trend where glaucoma patients are opting for permanent surgical solutions over long-term management using prescription drugs. This is due to the fact that glaucoma patients often need to take multiple medications at different stages of the disease, leading to compliance issues. Undergoing glaucoma surgery significantly reduces the medication burden for these patients. Moreover, challenges with medication such as low bioavailability, drug resistance, and toxicity have boosted the demand for surgical procedures and devices, thus contributing to market growth. Glaucoma surgery devices encompass a range of laser- and non-laser-based implants and other tools utilized to alleviate intraocular pressure by draining excess fluid accumulated in the eye. The glaucoma devices market is categorized into open-angle glaucoma and closed-angle glaucoma based on the type of treatment employed.

Market Dynamics

Drivers:

• Increased awareness and improved healthcare infrastructures
• Rising prevalence of glaucoma among the aging population
• Advancements in surgical techniques and technologies

Opportunities:

• Rise in the geriatric population and increase in healthcare expenditure
• Increasing need for minimally invasive glaucoma surgery (MIGS) treatments
• Increasing expenditure in healthcare sector globally

North America dominates the market for Glaucoma Surgery Devices.

North America dominated the market in 2023 capturing a significant share of total revenue. This region is projected to sustain its leading position in the upcoming forecast period. Key factors fueling growth in North America include the rising elderly population, the increasing diabetes prevalence due to lifestyle shifts, the growing obesity rates, and the high treatment costs. The American Diabetes Association reported that in 2021, North America and the Caribbean region recorded the highest diabetes expenditure at approximately USD 415 billion, representing 43% of the global spending. Furthermore, the market is being propelled by the adoption of innovative diabetes devices and advanced technologies like Artificial Intelligence (AI) and data analytics.

The Asia Pacific region is projected to experience the highest Compound Annual Growth Rate (CAGR) of throughout the forecast period. This market segment is primarily influenced by China and Japan. China held the top position in the regional market largely due to the presence of key market players and the high incidence of diabetes in the country. Furthermore, advancements in glaucoma surgery devices, a rising elderly population, and the increasing prevalence of lifestyle diseases like obesity are expected to drive the growth of the regional market in the future.

Top key players covered in the market report:

• Carl Zeiss Meditec AG
• Ziemer Ophthalmic Systems AG
• Altomed
• Johnson & Johnson Vision
• Alcon, Inc.
• Lumenis Lt.
• Glaukos Corporation
• Iridex Corporation
• ASICO

More for Information - Inquire Now!

Segmentations Analysis of Glaucoma Surgery Devices Market : -

• By Surgery Type
• By Products
• By Treatment
• By End User 
• By Region

About us:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

Contact Us: Email: sales@marketdigits.com